PLoS ONE (Jan 2024)

Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective

  • Nimer S. Alkhatib,
  • Abdulaali R. Almutairi,
  • Majid Almadi,
  • Shiraz Halloush,
  • Yazed Sulaiman H. Al-Ruthia,
  • Omar Rashdan,
  • Samah Al-Shatnawi,
  • Nahla A. Azzam,
  • Mahmoud H. Mosli,
  • Amal M. Badawoud,
  • Majed S. Al Yami,
  • Abdulaziz Alhossan,
  • Ibtisam AlHarbi

Journal volume & issue
Vol. 19, no. 11

Abstract

Read online

No abstracts available.